Latest Articles
Intense 68Ga-FAPI-04 Uptake in a Rare Case of Multifocal Abdominal Wall Endometriosis.
Fibroblast activation protein inhibitor (FAPI) PET is an emerging molecular imaging modality that is widely used in oncology and increasingly investigated in nononcologic diseases. Abdominal wall endometriosis (AWE) is a …
Published: Jan. 13, 2026, midnight
No checkpoint glory for Acrivon | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
No checkpoint glory for Acrivon | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: Jan. 12, 2026, 1:11 p.m.
Abdominal wall endometriosis in a caesarean section scar.
A woman in her 30s with a history of three caesarean sections was referred to gynaecology oncology for evaluation of abnormal uterine bleeding and a painful anterior abdominal wall mass …
Published: Jan. 12, 2026, midnight
Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer - Targeted Oncology
Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer Targeted Oncology
Published: Jan. 11, 2026, 4:14 p.m.
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - ETPharma.com
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty ETPharma.com
Published: Jan. 10, 2026, 1:55 a.m.
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - ET Pharma
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty ET Pharma
Published: Jan. 10, 2026, 1:55 a.m.
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology
Published: Jan. 5, 2026, 1:27 p.m.
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Jan. 5, 2026, 1:12 p.m.
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy - Targeted Oncology
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy Targeted Oncology
Published: Jan. 5, 2026, 1:07 p.m.
Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer - Targeted Oncology
Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer Targeted Oncology
Published: Dec. 23, 2025, 2:07 p.m.
Link copied to clipboard!